What is the difference between GLP-1 and SGLT2 drugs?
•
3 min read
Type 2 diabetes affects over 536 million people globally, often accompanied by significant cardiovascular and renal complications. For many, newer therapies like GLP-1 receptor agonists and SGLT2 inhibitors offer powerful management tools, but understanding what is the difference between GLP-1 and SGLT2 drugs is crucial for effective treatment. Both classes have distinct mechanisms that provide benefits beyond just blood sugar control, impacting weight, heart, and kidney health in different ways.
